167 related articles for article (PubMed ID: 33496731)
1. Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Joffe E; Leyfman Y; Drill E; Rajeeve S; Zelenetz AD; Palomba ML; Moskowitz CH; Portlock C; Noy A; Horwitz SM; Gerecitano JF; Moskowitz A; Hamlin P; Matasar MJ; Kumar A; Batlevi CL; Younes A; Straus DJ
Blood Adv; 2021 Jan; 5(2):345-351. PubMed ID: 33496731
[TBL] [Abstract][Full Text] [Related]
2. Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Freret ME; Tringale KR; Boe L; Imber BS; Joffe E; Yahalom J; Hajj C
Leuk Lymphoma; 2023 Dec; 64(13):2195-2201. PubMed ID: 37706509
[TBL] [Abstract][Full Text] [Related]
3. Bronchus-associated lymphoid tissue lymphomas.
Arnaoutakis K; Oo TH
South Med J; 2009 Dec; 102(12):1229-33. PubMed ID: 20016430
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
[TBL] [Abstract][Full Text] [Related]
5. A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
Sammassimo S; Pruneri G; Andreola G; Montoro J; Steffanoni S; Nowakowski GS; Gandini S; Negri M; Habermann TM; Raderer M; Li ZM; Zinzani PL; Adam P; Zucca E; Martinelli G
Hematol Oncol; 2016 Dec; 34(4):177-183. PubMed ID: 26152851
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
[TBL] [Abstract][Full Text] [Related]
7. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
[TBL] [Abstract][Full Text] [Related]
8. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].
Li X; Ye J; Yang L; Wei LQ; Cong J; Yao N; Yang J; Wang JW
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):209-214. PubMed ID: 35405778
[No Abstract] [Full Text] [Related]
10. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
Ronceray L; Abla O; Barzilai-Birenboim S; Bomken S; Chiang AK; Jazbec J; Kabickova E; Lazic J; Beishuizen A; Mellgren K; Tanaka F; Pillon M; Devalck C; Gouttenoire M; Makarova O; Burkhardt B; Attarbaschi A;
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286565
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma.
Gao LR; Wang X; Wu Y; Feng XL; Rao W; Liu X; Song YW; Fang H; Chen B; Jin J; Liu YP; Jing H; Tang Y; Lu NN; Li N; Zhang WW; Zhai Y; Wang SL; Qi SN; Li YX
Leuk Lymphoma; 2024 Jun; 65(6):746-757. PubMed ID: 38506231
[TBL] [Abstract][Full Text] [Related]
12. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
Borchmann S; Joffe E; Moskowitz CH; Zelenetz AD; Noy A; Portlock CS; Gerecitano JF; Batlevi CL; Caron PC; Drullinsky P; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz AJ; Owens CN; Palomba ML; Younes A; Straus DJ
Blood; 2019 May; 133(20):2121-2129. PubMed ID: 30770396
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in patients with extranodal marginal zone B-cell lymphoma of the lung.
Lee H; Yang B; Nam B; Jeong BH; Shin S; Zo JI; Shim YM; Kwon OJ; Lee KS; Kim H
J Thorac Cardiovasc Surg; 2017 Jul; 154(1):342-349. PubMed ID: 28457544
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database.
Stefanovic A; Morgensztern D; Fong T; Lossos IS
Leuk Lymphoma; 2008 Jul; 49(7):1311-20. PubMed ID: 18604720
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
17. Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M
Hematol Oncol; 2013 Dec; 31(4):183-8. PubMed ID: 23212941
[TBL] [Abstract][Full Text] [Related]
18. The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies.
Cortelazzo S; Rossi A; Oldani E; Motta T; Giardini R; Zinzani PL; Zucca E; Gomez H; Ferreri AJ; Pinotti G; Chini C; Devizzi L; Gianni AM; Cavalli F; Barbui T;
Br J Haematol; 2002 Jul; 118(1):218-28. PubMed ID: 12100151
[TBL] [Abstract][Full Text] [Related]
19. Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences.
de la Fuente MI; Haggiagi A; Moul A; Young RJ; Sidani C; Markoe A; Vega F; DeAngelis LM; Lossos IS
Leuk Lymphoma; 2017 Apr; 58(4):882-888. PubMed ID: 27649904
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma.
Imai H; Sunaga N; Kaira K; Kawashima O; Yanagitani N; Sato K; Tomizawa Y; Hisada T; Ishizuka T; Hirato J; Saito R; Nakajima T; Mori M
Intern Med; 2009; 48(5):301-6. PubMed ID: 19252351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
